+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Steroids Market - Global Forecast 2026-2032- Product Image
Topical Steroids Market - Global Forecast 2026-2032- Product Image
Sale

Topical Steroids Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6144848
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Steroids Market is projected to reach USD 5.00 Billion in 2026. It is expected to continue growing at a CAGR of 5.20%, reaching USD 6.78 Billion by 2032.

Topical Steroids: Executive Summary

Topical steroids are anti-inflammatory medicines used primarily to manage corticosteroid-responsive skin conditions, including eczema, dermatitis, psoriasis, and some allergic or irritant reactions. Their clinical value depends on matching potency, formulation, treatment site, patient age, and duration with the condition being treated. Responsible use requires attention to diagnosis, application instructions, contraindications, and follow-up because inappropriate or prolonged use can cause local and systemic adverse effects.

Safety-Conscious Care Is Reshaping Topical Steroid Use

Clinical practice is increasingly emphasizing potency stewardship, shorter treatment courses when appropriate, proactive management of relapsing disease, and patient education on fingertip-unit dosing and application frequency. Dermatology and primary-care pathways are also placing greater weight on distinguishing inflammatory disease from infection and other mimicking conditions. Access, affordability, prescription controls, availability of combination products, and demand for convenient formulations continue to influence how topical steroids are selected and used.

Artificial Intelligence Supports Diagnosis, Triage, and Treatment Oversight

Artificial intelligence can contribute to topical-steroid care by supporting image-based assessment, prioritizing referrals, identifying possible treatment-response patterns, and helping clinicians review longitudinal records. Its value is greatest when it augments-not replaces-clinical examination, patient history, and diagnostic testing where needed. Effective deployment requires representative datasets across skin tones, transparent validation, privacy safeguards, and clear human accountability, particularly because visual models may underperform when presentations are atypical or complicated by infection.

Regional Differences Reflect Access, Regulation, and Clinical Practice

North America is characterized by strong dermatology infrastructure, varied prescription and over-the-counter access, and heightened attention to labeling and safety communication. Latin America combines substantial dermatologic need with uneven access and diverse regulatory environments. Europe benefits from coordinated clinical guidance and established pharmacovigilance systems, while the Middle East shows varied specialist capacity and formulary access across countries. Africa faces disparities in diagnosis, medicine availability, and continuity of care. Asia-Pacific spans highly developed health systems and resource-constrained settings, creating wide differences in treatment access, prescribing practices, and patient education.

Economic and Policy Groups Shape Common Care Priorities

ASEAN markets share priorities around improving access, strengthening primary-care diagnosis, and addressing regulatory variation. BRICS members differ substantially in health-system capacity but commonly emphasize domestic pharmaceutical resilience and broader access to essential treatments. The European Union benefits from harmonized regulatory structures while retaining national differences in reimbursement and clinical implementation. G7 countries generally have mature safety monitoring and specialist networks, although affordability and access gaps remain. GCC states often combine strong urban healthcare infrastructure with imported-product dependence and cross-border practice influences. NATO members represent diverse health systems, making shared priorities such as supply continuity and evidence-based prescribing more relevant than uniform treatment pathways.

Country Contexts Require Localized Access and Stewardship Strategies

Australia and Canada combine established healthcare systems with geographically uneven specialist access. Brazil, Mexico, India, China, Russia, and South Africa face differing balances between public provision, private care, regulatory oversight, and regional availability. France, Germany, Italy, Spain, and the United Kingdom operate within mature European clinical and pharmacovigilance environments, while reimbursement and prescribing pathways vary. Japan and South Korea have advanced healthcare infrastructure and strong regulatory systems, with local practice patterns shaping product selection. In the United States, broad treatment availability coexists with affordability, insurance, and appropriate-use considerations. Across all listed countries, education on potency, duration, application technique, and follow-up remains central to safe use.

Prioritize Potency Stewardship, Access, and Evidence-Based Support

Industry leaders should align product communication with validated clinical guidance, clearly distinguish potency and formulation characteristics, and support prescribers with practical dosing and duration information. Patient-facing materials should explain correct application, expected benefits, warning signs, and when reassessment is needed without encouraging self-treatment of undiagnosed rashes. Organizations should strengthen pharmacovigilance, monitor supply continuity, and evaluate access barriers across public and private channels. Digital and AI-enabled tools should be introduced through prospective validation, bias testing across skin tones and age groups, cybersecurity controls, and clinician-led governance.

Methodology: Evidence-Led Synthesis of Clinical and Health-System Factors

This executive summary synthesizes established clinical principles and health-system considerations relevant to topical steroids, including therapeutic use, safety, access, regulation, diagnosis, and digital-health adoption. Regional, group, and country discussions are comparative rather than quantitative and are framed around documented differences in healthcare infrastructure, regulatory context, specialist capacity, and treatment access. No market estimates, market sizing, market shares, forecasts, or company-specific claims are used. Interpretation should be supplemented with current national labels, treatment guidelines, regulatory notices, and local epidemiological evidence before operational decisions are made.

Sustainable Value Depends on Appropriate, Accessible Treatment

Topical steroids remain important tools for controlling inflammatory skin disease, but their benefits depend on accurate diagnosis, appropriate potency and formulation, disciplined duration, and informed follow-up. The landscape is being shaped less by a single global pathway than by regional regulation, health-system capacity, affordability, and patient education. Leaders that combine safety stewardship, reliable access, high-quality evidence, and carefully governed digital support will be better positioned to improve outcomes while reducing preventable misuse.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of microneedle patch delivery systems for topical steroids efficacy enhancement
5.2. Emergence of liposomal and nanoparticle formulations improving steroid skin penetration rates
5.3. Expansion of low-potency over-the-counter topical steroids driven by consumer self-treatment trends
5.4. Increasing regulatory scrutiny on potency labeling and safety profiles for topical steroid prescriptions
5.5. Rising investments in patient adherence platforms and digital monitoring for long-term steroid therapies
5.6. Shift toward steroid-sparing biologics and combination therapies in chronic dermatological conditions
5.7. Patent expirations spurring generic competition and price erosion in the global topical steroid market
5.8. Sustainable packaging initiatives and green chemistry adoption in topical steroid production
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Topical Steroids Market, by Product Type
8.1. Introduction
8.2. Cream
8.3. Foam
8.4. Gel
8.5. Lotion
8.6. Ointment
8.7. Spray
9. Topical Steroids Market, by Potency Class
9.1. Introduction
9.2. Mild
9.3. Moderate
9.4. Potent
9.5. Super Potent
10. Topical Steroids Market, by Molecule
10.1. Introduction
10.2. Betamethasone
10.3. Clobetasol
10.4. Hydrocortisone
10.5. Mometasone
11. Topical Steroids Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.2.1. Private Hospital Pharmacy
11.2.2. Public Hospital Pharmacy
11.3. Online Pharmacy
11.3.1. Marketplace Pharmacy
11.3.2. Pure Play Pharmacy
11.4. Retail Pharmacy
11.4.1. Chain Pharmacy
11.4.2. Independent Pharmacy
12. Topical Steroids Market, by Indication
12.1. Introduction
12.2. Atopic Dermatitis
12.3. Eczema
12.4. Psoriasis
13. Topical Steroids Market, by End User
13.1. Introduction
13.2. Clinic
13.3. Homecare
13.4. Hospital
14. Americas Topical Steroids Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Topical Steroids Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Topical Steroids Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GlaxoSmithKline plc
17.3.2. Bayer AG
17.3.3. LEO Pharma A/S
17.3.4. Pfizer Inc.
17.3.5. Novartis AG
17.3.6. Johnson & Johnson
17.3.7. Viatris Inc.
17.3.8. Sandoz International GmbH
17.3.9. Galderma S.A.
17.3.10. Glenmark Pharmaceuticals Ltd
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. TOPICAL STEROIDS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TOPICAL STEROIDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TOPICAL STEROIDS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TOPICAL STEROIDS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. TOPICAL STEROIDS MARKET: RESEARCHAI
FIGURE 28. TOPICAL STEROIDS MARKET: RESEARCHSTATISTICS
FIGURE 29. TOPICAL STEROIDS MARKET: RESEARCHCONTACTS
FIGURE 30. TOPICAL STEROIDS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TOPICAL STEROIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOPICAL STEROIDS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TOPICAL STEROIDS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY FOAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY FOAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY LOTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY LOTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MODERATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MODERATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY POTENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY POTENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY SUPER POTENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY SUPER POTENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY BETAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY BETAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY CLOBETASOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY CLOBETASOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MOMETASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MOMETASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MARKETPLACE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY MARKETPLACE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PURE PLAY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PURE PLAY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY ECZEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY ECZEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES TOPICAL STEROIDS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 128. CANADA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 129. CANADA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 130. CANADA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 131. CANADA TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. CANADA TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. CANADA TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. CANADA TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. CANADA TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. CANADA TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. CANADA TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 138. CANADA TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 139. CANADA TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 146. MEXICO TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 147. MEXICO TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. MEXICO TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. MEXICO TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. MEXICO TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA TOPICAL STEROIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. GERMANY TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. GERMANY TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 238. GERMANY TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 239. GERMANY TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. GERMANY TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. GERMANY TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 244. GERMANY TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 245. GERMANY TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 246. GERMANY TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 247. GERMANY TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 248. GERMANY TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 249. GERMANY TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 250. GERMANY TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 251. GERMANY TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. GERMANY TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. FRANCE TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. FRANCE TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 256. FRANCE TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 257. FRANCE TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. FRANCE TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. FRANCE TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 262. FRANCE TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 263. FRANCE TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. FRANCE TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. FRANCE TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. FRANCE TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. FRANCE TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. FRANCE TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. FRANCE TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. FRANCE TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. ITALY TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. ITALY TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. ITALY TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 292. ITALY TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 293. ITALY TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 294. ITALY TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 295. ITALY TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. ITALY TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ITALY TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. ITALY TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. ITALY TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. ITALY TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. ITALY TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 302. ITALY TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 303. ITALY TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 304. ITALY TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 305. ITALY TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. ITALY TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SPAIN TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. SPAIN TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. SPAIN TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 310. SPAIN TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 311. SPAIN TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 312. SPAIN TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 313. SPAIN TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SPAIN TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. SPAIN TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 316. SPAIN TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 317. SPAIN TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. SPAIN TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. SPAIN TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. SPAIN TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. SPAIN TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 322. SPAIN TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 323. SPAIN TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. SPAIN TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 341. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. UNITED ARAB EMIRATES TOPICAL STEROIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA TOPICAL STEROIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2018-2024 (USD MILLION)
TABLE 346. SAUDI ARABIA TOPICAL STEROIDS MARKET SIZE, BY POTENCY CLASS, 2025-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 348. SAUDI ARABIA TOPICAL STEROIDS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA TOPICAL STEROIDS MARKET SIZE, BY DISTRIBUTION

Companies Mentioned

  • Bayer AG
  • Galderma S.A.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd
  • Johnson & Johnson
  • LEO Pharma A/S
  • Novartis AG
  • Pfizer Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Hydrocortisone - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Hydrocortisone - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Tinea Pedis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Tinea Pedis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Eczema Therapeutics Market - Global Forecast 2026-2032 - Product Image

Eczema Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Atopic Dermatitis Drugs Market - Global Forecast 2026-2032 - Product Image

Atopic Dermatitis Drugs Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Perioral Dermatitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Perioral Dermatitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.